Future studies investigating activated NLRP3 and the effects of CAPS-related mutations on the structural assembly of the NLRP3 inflammasome will provide valuable therapeutic insight into CAPS pathogenesis. Here, NLRP3 is linked to cryopyrin-associated periodic syndrome.